Pharmacology

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies. Read More

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience. Read More

A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior. Read More

With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County. Read More

Some patients may need a combo of medications to combat a condition that causes dizziness. Read More

Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes. Read More

A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications. Read More

Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS). Read More

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis. Read More

Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection. Read More

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. Read More

Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows. Read More

The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read More

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read More

In addition to her high school diploma, Aziza Hart earned an unusual honor this spring – her first scientific paper was published in a new Vanderbilt University journal, Young Scientist. Hart, who graduated from Nashville’s Glencliff High School, spent part of her senior year in a Vanderbilt laboratory, studying… Read More

A certain signaling pathway could be key to improving cardiac repair after a heart attack. Read More

Abnormalities of the hippocampus, a seahorse-shaped brain region involved in learning and memory, may play a role in the psychotic symptoms and cognitive deficits of schizophrenia. Read More

A new understanding of the biochemical pathway that builds our skin barrier could lead to treatments for skin diseases. Read More

Cocaine exposure during the teen years causes long-lasting brain and behavioral changes in rats. Read More

Discovery of a new class of insect repellant raises the possibility of formulations that are thousands of times more effective than current repellants. Read More